EQUASENS (EQS.PA) Stock Fundamental Analysis
EPA:EQS - Euronext Paris - Matif - FR0012882389 - Common Stock - Currency: EUR
EQS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 13 industry peers in the Health Care Technology industry. EQS gets an excellent profitability rating and is at the same time showing great financial health properties. EQS has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
EQS had positive earnings in the past year.
EQS had a positive operating cash flow in the past year.
In the past 5 years EQS has always been profitable.
Each year in the past 5 years EQS had a positive operating cash flow.
1.2 Ratios
The Return On Assets of EQS (10.45%) is better than 83.33% of its industry peers.
Looking at the Return On Equity, with a value of 19.87%, EQS belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
EQS has a better Return On Invested Capital (14.93%) than 91.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EQS is significantly above the industry average of 9.30%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.45% | ||
| ROE | 19.87% | ||
| ROIC | 14.93% |
ROA(3y)12.34%
ROA(5y)11.68%
ROE(3y)23.5%
ROE(5y)22.83%
ROIC(3y)17.88%
ROIC(5y)18.18%
1.3 Margins
EQS's Profit Margin of 19.64% is amongst the best of the industry. EQS outperforms 83.33% of its industry peers.
EQS's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 22.49%, EQS belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
EQS's Operating Margin has been stable in the last couple of years.
EQS has a Gross Margin of 68.63%. This is in the lower half of the industry: EQS underperforms 66.67% of its industry peers.
In the last couple of years the Gross Margin of EQS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.49% | ||
| PM (TTM) | 19.64% | ||
| GM | 68.63% |
OM growth 3Y-2.18%
OM growth 5Y-0.84%
PM growth 3Y6.2%
PM growth 5Y4.59%
GM growth 3Y-0.43%
GM growth 5Y0.31%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EQS is creating value.
The number of shares outstanding for EQS has been increased compared to 1 year ago.
The number of shares outstanding for EQS has been increased compared to 5 years ago.
Compared to 1 year ago, EQS has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.44 indicates that EQS is not in any danger for bankruptcy at the moment.
The Altman-Z score of EQS (3.44) is better than 75.00% of its industry peers.
EQS has a debt to FCF ratio of 1.67. This is a very positive value and a sign of high solvency as it would only need 1.67 years to pay back of all of its debts.
EQS has a Debt to FCF ratio of 1.67. This is in the better half of the industry: EQS outperforms 66.67% of its industry peers.
EQS has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
EQS has a better Debt to Equity ratio (0.15) than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.67 | ||
| Altman-Z | 3.44 |
ROIC/WACC1.95
WACC7.67%
2.3 Liquidity
A Current Ratio of 1.09 indicates that EQS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.09, EQS is in line with its industry, outperforming 41.67% of the companies in the same industry.
EQS has a Quick Ratio of 1.00. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
EQS has a Quick ratio of 1.00. This is comparable to the rest of the industry: EQS outperforms 41.67% of its industry peers.
The current and quick ratio evaluation for EQS is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The earnings per share for EQS have decreased strongly by -12.99% in the last year.
EQS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.04% yearly.
Looking at the last year, EQS shows a decrease in Revenue. The Revenue has decreased by -3.56% in the last year.
The Revenue has been growing by 8.16% on average over the past years. This is quite good.
EPS 1Y (TTM)-12.99%
EPS 3Y15.35%
EPS 5Y13.04%
EPS Q2Q%-21.89%
Revenue 1Y (TTM)-3.56%
Revenue growth 3Y8.56%
Revenue growth 5Y8.16%
Sales Q2Q%-4.1%
3.2 Future
The Earnings Per Share is expected to grow by 0.67% on average over the next years.
The Revenue is expected to grow by 5.58% on average over the next years.
EPS Next Y-27.4%
EPS Next 2Y-3.86%
EPS Next 3Y0.67%
EPS Next 5YN/A
Revenue Next Year-5.14%
Revenue Next 2Y1.81%
Revenue Next 3Y5.84%
Revenue Next 5Y5.58%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 13.29, EQS is valued correctly.
EQS's Price/Earnings ratio is rather cheap when compared to the industry. EQS is cheaper than 91.67% of the companies in the same industry.
EQS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.78.
Based on the Price/Forward Earnings ratio of 12.66, the valuation of EQS can be described as correct.
Based on the Price/Forward Earnings ratio, EQS is valued cheaper than 83.33% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of EQS to the average of the S&P500 Index (21.32), we can say EQS is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.29 | ||
| Fwd PE | 12.66 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, EQS is valued a bit cheaper than 75.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, EQS is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.52 | ||
| EV/EBITDA | 8.12 |
4.3 Compensation for Growth
EQS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.02
EPS Next 2Y-3.86%
EPS Next 3Y0.67%
5. Dividend
5.1 Amount
EQS has a Yearly Dividend Yield of 3.36%. Purely for dividend investing, there may be better candidates out there.
EQS's Dividend Yield is a higher than the industry average which is at 4.06.
EQS's Dividend Yield is a higher than the S&P500 average which is at 2.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.36% |
5.2 History
The dividend of EQS is nicely growing with an annual growth rate of 8.96%!
Dividend Growth(5Y)8.96%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
44.47% of the earnings are spent on dividend by EQS. This is a bit on the high side, but may be sustainable.
EQS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP44.47%
EPS Next 2Y-3.86%
EPS Next 3Y0.67%
EPA:EQS (4/25/2025, 7:00:00 PM)
36.95
-0.25 (-0.67%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners13.44%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap560.53M
Analysts83.33
Price Target60.69 (64.25%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.36% |
Yearly Dividend1.15
Dividend Growth(5Y)8.96%
DP44.47%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.57%
PT rev (3m)-14.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-14.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.29 | ||
| Fwd PE | 12.66 | ||
| P/S | 2.61 | ||
| P/FCF | 18.52 | ||
| P/OCF | 11.41 | ||
| P/B | 2.64 | ||
| P/tB | 8.24 | ||
| EV/EBITDA | 8.12 |
EPS(TTM)2.78
EY7.52%
EPS(NY)2.92
Fwd EY7.9%
FCF(TTM)2
FCFY5.4%
OCF(TTM)3.24
OCFY8.76%
SpS14.18
BVpS14.02
TBVpS4.48
PEG (NY)N/A
PEG (5Y)1.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.45% | ||
| ROE | 19.87% | ||
| ROCE | 17.39% | ||
| ROIC | 14.93% | ||
| ROICexc | 19.32% | ||
| ROICexgc | 59.06% | ||
| OM | 22.49% | ||
| PM (TTM) | 19.64% | ||
| GM | 68.63% | ||
| FCFM | 14.07% |
ROA(3y)12.34%
ROA(5y)11.68%
ROE(3y)23.5%
ROE(5y)22.83%
ROIC(3y)17.88%
ROIC(5y)18.18%
ROICexc(3y)23.8%
ROICexc(5y)24.68%
ROICexgc(3y)70.74%
ROICexgc(5y)71.14%
ROCE(3y)20.83%
ROCE(5y)21.18%
ROICexcg growth 3Y-16.59%
ROICexcg growth 5Y-12.82%
ROICexc growth 3Y-7.85%
ROICexc growth 5Y-8.24%
OM growth 3Y-2.18%
OM growth 5Y-0.84%
PM growth 3Y6.2%
PM growth 5Y4.59%
GM growth 3Y-0.43%
GM growth 5Y0.31%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.67 | ||
| Debt/EBITDA | 0.51 | ||
| Cap/Depr | 130.21% | ||
| Cap/Sales | 8.76% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 78.14% | ||
| Profit Quality | 71.64% | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 3.44 |
F-Score5
WACC7.67%
ROIC/WACC1.95
Cap/Depr(3y)98.83%
Cap/Depr(5y)145.04%
Cap/Sales(3y)6.18%
Cap/Sales(5y)8.15%
Profit Quality(3y)93.06%
Profit Quality(5y)90.44%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.99%
EPS 3Y15.35%
EPS 5Y13.04%
EPS Q2Q%-21.89%
EPS Next Y-27.4%
EPS Next 2Y-3.86%
EPS Next 3Y0.67%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.56%
Revenue growth 3Y8.56%
Revenue growth 5Y8.16%
Sales Q2Q%-4.1%
Revenue Next Year-5.14%
Revenue Next 2Y1.81%
Revenue Next 3Y5.84%
Revenue Next 5Y5.58%
EBIT growth 1Y-15.41%
EBIT growth 3Y6.19%
EBIT growth 5Y7.25%
EBIT Next Year-5.14%
EBIT Next 3Y14.95%
EBIT Next 5YN/A
FCF growth 1Y-27.84%
FCF growth 3Y12.59%
FCF growth 5Y17.34%
OCF growth 1Y-3.3%
OCF growth 3Y6.93%
OCF growth 5Y14.97%